DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Halozyme Therapeutics, Inc. (HALO)
« Back to company indexHALO Chatter Timeline
Stock Ticker for HALO
Most Active Tweeters for HALO
| User | Tweets |
|---|---|
| @fezziwig2008 | 35 |
| @dapstats | 6 |
| @SolarMelt | 4 |
| @CannabisFN | 4 |
| @AmericanBanking | 3 |
Recent Tweets for HALO
 |
@BrazeauErin RT @Technical420: Halo Labs to Expand Globally and Acquire Bophelo Bioscience $HALO $LABS https://t.co/nikCE9RwCZ June 17th 2019, 7:06pm |
 |
@Technical420 Halo Labs to Expand Globally and Acquire Bophelo Bioscience $HALO $LABS https://t.co/nikCE9RwCZ June 17th 2019, 6:06pm |
|
@BrazeauErin RT @mmjinvesting: HALO LABS $HALO TO EXPAND GLOBALLY AND ACQUIRE BOPHELO BIOSCIENCE https://t.co/KqW65rkmjN #potstocks #investing #extrac… June 17th 2019, 6:06pm |
 |
@CannabisFN $HALO $AGEEF The Transaction is expected to strengthen #HaloLabs' position in Lesotho, Africa, a country quickly be… https://t.co/j1prPazQM4 June 17th 2019, 6:06pm |
 |
@thestoxlab RT mmjinvesting "HALO LABS $HALO TO EXPAND GLOBALLY AND ACQUIRE BOPHELO BIOSCIENCE https://t.co/j0gEbq9ogI… https://t.co/RsLaDXm4xO June 17th 2019, 5:06pm |
 |
@mmjinvesting HALO LABS $HALO TO EXPAND GLOBALLY AND ACQUIRE BOPHELO BIOSCIENCE https://t.co/KqW65rkmjN #potstocks #investing… https://t.co/GPJ9KSdqem June 17th 2019, 5:06pm |
 |
@CanadaPotstocks News: $Halo Labs to acquire pot firm Bophelo for 40.78M shares https://t.co/5u66MfGq0i June 17th 2019, 5:06pm |
 |
@InsiderAlertsIA $HALO: New Insider Filing on SVP, Chief Financial Officer LAURIE STELZER: https://t.co/l5lmGGC8aj June 17th 2019, 9:06am |
 |
@StockTexts $HALO Halozyme Therapeutics, Inc. SEC Filing: Form 4 https://t.co/DEtBRGGhQi June 17th 2019, 8:06am |
 |
@iamtito_ $HALO - Statement of Changes in Beneficial Ownership (4) https://t.co/abr87r39Y1 June 17th 2019, 8:06am |
 |
@fezziwig2008 $HALO Enhanze expanding scope of $BMY Opdivo Solid Tumor Trial https://t.co/fAk7BQND9i June 15th 2019, 3:06pm |
 |
@AlexandriaCairo RT @fezziwig2008: $HALO data maturity “when all pts Enrolled have been followed for @ least 8.5 mos” but 1/2 receiving just Gem-Abrax don’… June 15th 2019, 2:06pm |
|
@fezziwig2008 $HALO data maturity “when all pts Enrolled have been followed for @ least 8.5 mos” but 1/2 receiving just Gem-Abra… https://t.co/jAeUVJsRHx June 15th 2019, 2:06pm |
|
@fezziwig2008 UCLA is using the same Hyaluronan Assay developed by $RHHBY Ventanas being used in $HALO P3 Trial- “using a novel h… https://t.co/5UFY1VgVVn June 15th 2019, 9:06am |
 |
@Aesculapius1898 RT @fezziwig2008: Are we clear now? High Hyaluronan Causes Metastasis- Crystal. $HALO targets. https://t.co/r0BJvuCp31 June 14th 2019, 4:06pm |
|
@fezziwig2008 Are we clear now? High Hyaluronan Causes Metastasis- Crystal. $HALO targets. https://t.co/r0BJvuCp31 June 14th 2019, 12:06pm |
 |
@Gambiste1 RT @SolarMelt: $GLYC and $HALO both have Sentiment in an uptrend and set to crossover to positive on a good day tomorrow. Potential run-up… June 14th 2019, 8:06am |
 |
@OlympiaReport Halozyme Therapeutics $HALO Lifted to “Hold” at BidaskClub https://t.co/mTqpLIsl4f June 14th 2019, 8:06am |
 |
@SolarMelt $GLYC and $HALO both have Sentiment in an uptrend and set to crossover to positive on a good day tomorrow. Potentia… https://t.co/UzO8w8izFs June 13th 2019, 8:06pm |
 |
@rb01234 RT @fezziwig2008: So approximately 170 pts are still alive in $HALO P3 Metastatic #PancreaticCancer Trial over 3 yrs from onset. June 13th 2019, 2:06pm |
|
@fezziwig2008 RT @fezziwig2008: $HALO preclinical 2014 paper showing Hyaluronan accumulation favors metastasis via e-Cadherin translocation from plasma m… June 13th 2019, 2:06pm |
|
@fezziwig2008 $HALO preclinical 2014 paper showing Hyaluronan accumulation favors metastasis via e-Cadherin translocation from pl… https://t.co/6woTktzGg1 June 13th 2019, 12:06pm |
|
@fezziwig2008 UCLA just showed High Levels of Hyaluronan promotes Lymphatic Metastases in #PancreaticCancer - $HALO removes HA an… https://t.co/COjIp9k79M June 13th 2019, 10:06am |
|
@fezziwig2008 RT @fezziwig2008: By mid Sept-last few pts recruited for $HALO P3 in “late Dec” will have survived the 8.5 mo cut off - interesting that al… June 13th 2019, 10:06am |
|
@fezziwig2008 By mid Sept-last few pts recruited for $HALO P3 in “late Dec” will have survived the 8.5 mo cut off - interesting t… https://t.co/wn9z5LSyug June 13th 2019, 9:06am |
 |
@AntounNabhan Wishing luck to Helen and her team at $HALO — and the patients involved. Pancreatic cancer is one of the tumor type… https://t.co/gO98u7tz3P June 13th 2019, 9:06am |
 |
@Biotech2050 RT @mikegoodma: $HALO announced that P3 trial of PEGPH20 for advanced pancreatic cancer has reached the target number (330) of survival eve… June 13th 2019, 7:06am |
 |
@mikegoodma $HALO announced that P3 trial of PEGPH20 for advanced pancreatic cancer has reached the target number (330) of surv… https://t.co/wzSNqKoVHg June 13th 2019, 7:06am |
 |
@macondailynews Halozyme Therapeutics $HALO Upgraded at BidaskClub https://t.co/dRGZP3sRLM June 13th 2019, 5:06am |
 |
@MaisaCorp $HALO has reached the target number of 330 overall survival events in its HALO-301 clinical trial. $HALO projects… https://t.co/8iULI1SHOP June 12th 2019, 4:06pm |
 |
@FrankQuintieri @fezziwig2008 And yet market ignores $HALO https://t.co/WY9MeQFgi9 June 12th 2019, 3:06pm |
 |
@Briefingcom $HALO: Halozyme Therapeutics reaches target number of 330 overall survival events in HALO-301 clinical trial, plans… https://t.co/HriX4hU1De June 12th 2019, 3:06pm |
|
@fezziwig2008 Longest OS in Met #PancreaticCancer Trial -Folfirinox-10-11 mos - $HALO meets primary endpoint w/minimum of 2.2 mos… https://t.co/6dtz6ga1iT June 12th 2019, 2:06pm |
|
@Biotech2050 RT @_B_I_O_T_E_C_H_: $HALO HALOZYME THERAPEUTICS INC SAYS REACHED TARGET NUMBER OF 330 OVERALL SURVIVAL EVENTS IN… June 12th 2019, 2:06pm |
 |
@SeasonalEdge Today's insight on $HALO https://t.co/zLc5ZPkIAe https://t.co/SLs8YhToBP June 12th 2019, 2:06pm |
 |
@1MinuteStock Recommendation Moderate #SELL for $HALO with UB rating - 1.47 out of 5. https://t.co/KiEuRAHduR June 12th 2019, 2:06pm |
|
@fezziwig2008 So approximately 170 pts are still alive in $HALO P3 Metastatic #PancreaticCancer Trial over 3 yrs from onset. June 12th 2019, 2:06pm |
 |
@MarketCurrents $HALO - Halozyme on track for key data readout in Q4 https://t.co/gxEjuC53nB June 12th 2019, 2:06pm |
 |
@MSollender $HALO Reaches target number of 330 overall survival events in HALO-301; will conduct final survival analysis after… https://t.co/OoOXmewZrY June 12th 2019, 2:06pm |
|
@fezziwig2008 OS same as Mpact - median - meaning 1/2 lived less than 8.5 months in MPact Trial - but all of $HALO 330 pts in P3… https://t.co/oJuNBrz1m0 June 12th 2019, 2:06pm |
 |
@_B_I_O_T_E_C_H_ $HALO HALOZYME THERAPEUTICS INC SAYS REACHED TARGET NUMBER OF 330 OVERALL SURVIVAL EVENTS… https://t.co/UKNapuJ3Z4 June 12th 2019, 2:06pm |
|
@fezziwig2008 $HALO 8-K out today -target # events reached in P3 data maturity when ALL have reached 8.5 mos- mid Sept ‘19 -top l… https://t.co/oBu6pSacra June 12th 2019, 2:06pm |
 |
@fintel_io Also, if you are new to $HALO here's some background for you https://t.co/X7J1acws0Y June 12th 2019, 1:06pm |
|
@fintel_io $HALO / Halozyme Therapeutics files form 8-K https://t.co/QjppGjdP7J - Other Events June 12th 2019, 1:06pm |
|
@StockTexts $HALO Halozyme Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/4m4iwAJGIS June 12th 2019, 1:06pm |
 |
@filingsdb New Form 8-K filed by HALOZYME THERAPEUTICS INC $HALO - https://t.co/8fuRKqGPN4 June 12th 2019, 1:06pm |
|
@Gambiste1 RT @fezziwig2008: $HALO presenting today- The Goldman Sachs 40th Annual Global Healthcare Conference on Wednesday, June 12 at 1:40 PM ET /… June 12th 2019, 10:06am |
|
@fezziwig2008 $HALO presenting today- The Goldman Sachs 40th Annual Global Healthcare Conference on Wednesday, June 12 at 1:40 PM… https://t.co/ymukjqya0s June 12th 2019, 10:06am |
|
@CannabisFN RT @CannabisFN: ...If done correctly, MSOs can result in huge payoffs. Case in point: $AGEEF $HALO #HaloLabs, which manufactures #cannabis… June 12th 2019, 10:06am |
|
@CannabisFN ...If done correctly, MSOs can result in huge payoffs. Case in point: $AGEEF $HALO #HaloLabs, which manufactures… https://t.co/1zkxbrny5U June 12th 2019, 9:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.